GENE ONLINE|News &
Opinion
Blog

Avexis
After FDA Lifts Hold, Novartis to Proceed with Clinical Trials for Expensive Rare Disease Therapy
2021-08-04
Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases
2020-08-03
Spotlight: Roche’s SMA Drug, Risdiplam Makes Strong Case for Regulatory Approval
2020-07-05
FDA Okays Expensive Gene Therapy for Infantile-Onset Spinal Muscular Atrophy
2019-05-29
M&A
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
LATEST
Healthcare+ Expo Taiwan 2024 To Become A Global Trade Fair With 600+ Companies Attending
2024-11-29
Cracking the Code: How Genetics Shapes Strength, Power, and Speed in Sports
2024-11-27
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
MIRDC Hosts Seminar Featuring Diverse Applications of Plasma Sterilization Technology
2024-11-26
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top